Sid Martin Biotechnology Incubator

Last updated
UF Innovate | Sid Martin Biotech
Alachua Fl Sid Martin Biotechnology Incubator04.jpg
MottoWe help entrepreneurs feed, fuel and heal the world.
Established1990 - Facility opened Fall 1995
Parent institution
University of Florida
DirectorKarl R. LaPan, MBA
United States
[1] [2]

UF Innovate | Sid Martin Biotech is located in Alachua, Florida, in Progress Park. The program's mission is to foster the growth of bioscience startup companies that have some relationship to the University. The Incubator works with companies in all product areas relating to the life sciences, biomedical research, medicine, and chemical sciences.



UF Innovate | Sid Martin Biotech (formerly known as Sid Martin Biotechnology Development Institute) was officially founded on July 2, 1990 by the Florida Legislature. It was named after Sid Martin, a member of the Florida House of Representatives, in recognition of his commitment to the state of Florida and the University of Florida. In 1994, the Trustees at the University of Florida authorized 6 acres (24,000 m2) to build the Sid Martin Biotech Incubator.

The Incubator is 40,000 square feet (3,700 m2) and was built with a combination of funding from the University of Florida, the United States Department of Agriculture, and the Florida Legislature. The facility was created, engineered, equipped, and opened in 1995 as one of the first bio-business incubators in the United States. [2] Approximate cost at that time was $11.5 million. The facility is located just outside Gainesville, Florida in the Progress Corporate Park. Much of this research park was a product of the vision of former University of Florida President, Robert Q. Marston.

Graduate companies

Over 60 biotechnology startups have graduated from SMBI and become self-sufficient companies or were acquired. Among them are:


In 2004, the facility's Director was reported to be David L. Day. [4] By 2014, this role had been conferred upon Patti Breedlove. [1]

Breedlove had previously been reported to be the Incubator's Manager (2007), [2] and later its Associate Director (2011). [5] She retired at the end of 2015, and Mark Long became director in 2016. Long retired in 2021 and Karl R. LaPan, MS, became Director; Elliott Welker, MBA, is the Assistant Director.

Resident companies

Sid Martin Biotech supports a wide range of bioscience companies including Erivan Bio, clean tech, diagnostic, therapeutic, drug delivery, genomic, bio-medical device, agbio, biofuels, and others. The Incubator can host up to twenty resident companies at the facility. As of 2020, Sid Martin Biotech companies have attracted more than $8.9 billion in equity investment, sales revenue, contracts, grants, and M&A activity. [1]

International recognition

In 2007, the National Business Incubator Association(NBIA) recognized Sid Martin Biotech with a second-place ranking in the Technology category of its annual Incubator of the Year award program. [2] In 2013, the University Business Incubators group (UBI Global) ranked Sid Martin Biotech as "World's Best University Biotech Incubator" among 150 contenders across 22 countries. [1] The same year, 2013, Sid Martin Biotech won the NBIA's "Incubator of the Year" award. [6] April 3, 2017 - Sid Martin Biotechnology Institute (SMBI), the leading biotechnology incubator at the University of Florida, has been awarded the Randall M. Whaley Incubator of the Year award for 2017, the highest award given by the International Business Innovation Association (InBIA). The Sid Martin Biotechnology Incubator program received a third Randall M. Whaley Incubator of the Year award in 2021.

See also

Related Research Articles

PerkinElmer American corporation focused on life science research

PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. PerkinElmer produces analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets.

Genome Valley

Genome Valley is an Indian high technology business district spread across 600 km² in Hyderabad, India. It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for biomedical research, training and manufacturing.

Arthur D. Levinson is an American businessman and is the current chairman of Apple Inc. (2011–present) and CEO of Calico. He is the former chief executive officer (1995–2009) and chairman (1999–2014) of Genentech.

Thermo Fisher Scientific Provisioner of scientific consumables, equipment, and services

Thermo Fisher Scientific is an American supplier of scientific instrumentation, reagents and consumables, and software services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher has acquired other reagent, consumable, instrumentation, and service providers, including: Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), and BD Advanced Bioprocessing (2018).

Sartorius AG German pharmaceutical company

Sartorius AG is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services.

The US Market Access Center, located in Menlo Park, is a business accelerator and trade gateway into the United States for high-tech international companies. The USMAC specializes in US market entry for small to mid-sized, high-growth companies in the information and communications, clean technology, and the life sciences sectors planning to expand their marketing, sales and operations to the United States.

The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three campuses of the University of California in the San Francisco Bay Area: Berkeley, San Francisco, and Santa Cruz. QB3's domain is the quantitative biosciences: areas of biology in which advances are chiefly made by scientists applying techniques from physics, chemistry, engineering, and computer science.

Ohio bioscience sector Significant economic sector in the state

The Ohio bioscience sector strength was ranked #4 among USA states in 2008 by Business Facilities magazine.

EnCor Biotechnology

EnCor Biotechnology is a United States company that manufactures antibodies to neural and yeast proteins. Founded in 1999 as a spin-off from the University of Florida by Gerry Shaw, a British scientist and professor at the University of Florida, the company is based in Gainesville, Florida and markets antibody reagents originally made for research purposes, but which also have commercial value.

The San Jose BioCenter is a business incubator formed as a university foundation in 2004 and focused on the initiation and development of technology companies, with an emphasis on the life sciences industry. The BioCenter emerged from San Jose State University in an effort to revitalize an industrial area of San Jose, California. As of 2012, the BioCenter had thirty-five member (assisted) companies and twelve affiliate (supporting) companies. In addition to office space, the BioCenter provides wet laboratory facilities to member companies.

Francesco De Rubertis is a partner at medicxi, a venture capital firm with offices in London, Jersey and Geneva, having co-founded the firm in February 2016. Prior to that he was a partner at another venture capital firm, Index Ventures, having led the firm's efforts to establish its life sciences practice after joining in 1997.

BioMotiv is an accelerator company associated with The Harrington Project, a $340 million initiative centered at University Hospitals of Cleveland. Therapeutic opportunities are identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.

Ology Bioservices is a private, American biopharmaceutical company headquartered in Alachua, Florida. The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. In 2016, the company changed their strategic focus and became a biologics contract development and manufacturing company (CDMO) specializing in the manufacturing of vaccines, monoclonal antibodies, recombinant proteins, virus and nucleic acids.

Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, Tocris Biosciences, and Novus Biologicals.

The NanKang Biotech Incubation Center (NBIC) is a biotech incubator formed by the SME Foundation of the Ministry of Economic Affairs, ROC and managed by the Development Center for Biotechnology. The incubator focuses on the initiation and development of biotech startups with an emphasis of the biotech industry including pharmaceuticals, medical devices and applied biotech. NBIC is a model incubator in biotech industry, different from the university affiliated incubator, supported by the SME Foundation. As of 2015, the incubator has 21 Class I client companies, 1 Class II, and 20 Class III. Beside office space, the incubator provides wet laboratory with instruments and facilities.

Kevin Lustig

Kevin Donald Lustig is a male American scientist and entrepreneur and founder of three life science companies: the pharmaceutical company Kalypsys in 2001; the online research marketplace in 2007; and the non-profit lab incubator Bio, Tech and Beyond in 2013.

Alexandria Real Estate Equities American real estate company

Alexandria Real Estate Equities, Inc. is an American real estate investment trust that invests in office buildings and laboratories leased to tenants in the life science and technology industries.

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in New York City, U.S.

William Rastetter American scientist, entrepreneur and venture capitalist

William H.Rastetter, a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics, and of Daré Bioscience, Inc. in San Diego, California. He is a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company's interim CEO (2017) and chair (2017-2018). Rastetter is also a director of Regulus Therapeutics. He was a partner in the venture firm Venrock (2006-2013), and a trustee at Caltech (2015-2018). He has served as a director (1998-2016) and as chair of Illumina (2005-2016). He advised SVB Leerink (2014-2019) and currently advises Illumina Ventures.

10x Genomics Company in Pleasanton, United States

10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.


  1. 1 2 3 4 5 Philipiddis, Alex (15 June 2014). "Incubators Blossom along with Their Startups". Genetic Engineering & Biotechnology News . Vol. 34, no. 12. pp. 7–8. Retrieved 2016-07-17.
  2. 1 2 3 4 Goodwin, Jay (4 April 2007). "UF business incubator recognized internationally". University of Florida News. Archived from the original on 4 July 2008.
  3. 1 2 3 Staff (1 February 2005). "A few Florida nanotechnology companies have real products". Eyes on the market. Florida Trend . NanoMedex. Archived from the original on 10 September 2016. Retrieved 2016-07-17 via HighBeam Research.
  4. Haggman, Matthew (9 November 2004). "Biotechnology firms vie for funding at Miami forum". Knight Ridder/Tribune Business News. Archived from the original on 10 September 2016. Retrieved 2016-07-17 via HighBeam Research.
  5. Staff (18 May 2011). "Celebrate Biotechnology in Florida". Education Letter. Archived from the original on 10 September 2016. Retrieved 2016-07-17 via HighBeam Research.
  6. DiGregorio, Kevin (3 April 2014). "Revitalizing the State's Chemical Industry". Charleston Daily Mail . Archived from the original on 11 September 2016. Retrieved 2016-07-17 via HighBeam Research.

Commons-logo.svg Media related to Sid Martin Biotechnology Incubator at Wikimedia Commons